[go: up one dir, main page]

NO20000722L - 2- (4-aryl or heteroaryl-piperazin-1-ylmethyl) -1H-indole derivatives - Google Patents

2- (4-aryl or heteroaryl-piperazin-1-ylmethyl) -1H-indole derivatives

Info

Publication number
NO20000722L
NO20000722L NO20000722A NO20000722A NO20000722L NO 20000722 L NO20000722 L NO 20000722L NO 20000722 A NO20000722 A NO 20000722A NO 20000722 A NO20000722 A NO 20000722A NO 20000722 L NO20000722 L NO 20000722L
Authority
NO
Norway
Prior art keywords
piperazin
ylmethyl
heteroaryl
aryl
indole derivatives
Prior art date
Application number
NO20000722A
Other languages
Norwegian (no)
Other versions
NO20000722D0 (en
Inventor
Anton Franz Josef Fliri
Marc J Majchrzak
Patricia Ann Seymour
Stevin Howard Zorn
Hans Rollema
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20000722L publication Critical patent/NO20000722L/en
Publication of NO20000722D0 publication Critical patent/NO20000722D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Forbindelse ifølge formel (l) hvori a, T, V, X, Y, Z, R1, R2, R3, R4, R5, R6, R7, R8 og R9 er som definert, farmasøytisk akseptable salter og farmasøytiske blandinger inneholdende slike forbindelser og deres salter.A compound of formula (I) wherein a, T, V, X, Y, Z, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined, pharmaceutically acceptable salts and pharmaceutical compositions containing such compounds and their salts.

NO20000722A 1997-08-15 2000-02-14 2- (4-aryl or heteroaryl-piperazin-1-ylmethyl) -1H-indole derivatives NO20000722D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5576497P 1997-08-15 1997-08-15
PCT/IB1998/001198 WO1999009025A2 (en) 1997-08-15 1998-08-05 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor

Publications (2)

Publication Number Publication Date
NO20000722L true NO20000722L (en) 2000-02-14
NO20000722D0 NO20000722D0 (en) 2000-02-14

Family

ID=22000003

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000722A NO20000722D0 (en) 1997-08-15 2000-02-14 2- (4-aryl or heteroaryl-piperazin-1-ylmethyl) -1H-indole derivatives

Country Status (30)

Country Link
EP (1) EP1003739A2 (en)
JP (1) JP2002536291A (en)
KR (1) KR20010022507A (en)
CN (1) CN1265660A (en)
AP (1) AP9801321A0 (en)
AR (1) AR017019A1 (en)
AU (1) AU8457298A (en)
BG (1) BG104069A (en)
BR (1) BR9811557A (en)
CA (1) CA2297486C (en)
CO (1) CO4960656A1 (en)
DZ (1) DZ2583A1 (en)
EA (1) EA200000023A1 (en)
HR (1) HRP980441A2 (en)
HU (1) HUP0003425A3 (en)
ID (1) ID23803A (en)
IL (1) IL133960A0 (en)
IS (1) IS5336A (en)
MA (1) MA24632A1 (en)
NO (1) NO20000722D0 (en)
OA (1) OA11286A (en)
PA (1) PA8457001A1 (en)
PE (1) PE106299A1 (en)
PL (1) PL338947A1 (en)
SK (1) SK1352000A3 (en)
TN (1) TNSN98151A1 (en)
TR (1) TR200000414T2 (en)
UY (1) UY25144A1 (en)
WO (1) WO1999009025A2 (en)
ZA (1) ZA987304B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9813279B1 (en) * 1997-10-27 2010-11-16 homopiperazine derivative, pharmaceutical composition, and use of the homopiperazine derivative.
EP0953567A3 (en) * 1998-04-29 2003-04-02 Pfizer Products Inc. Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity
BR0016953A (en) 1999-12-30 2003-02-25 Lundbeck & Co As H Halogen substituted 4-phenyl-1-piperazinyl, piperidinyl and tetrahydropyridyl derivatives, compound, pharmaceutical composition, use and method of treatment
GB0017952D0 (en) * 2000-07-22 2000-09-13 Univ Manchester Treatment of dyskinesia
EP1177792A3 (en) 2000-07-27 2002-10-23 Pfizer Products Inc. Dopamine D4 Ligands for the treatment of novelty-seeking disorders
JP4544820B2 (en) * 2001-03-09 2010-09-15 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド Heterocyclic compounds
UA79309C2 (en) 2002-09-06 2007-06-11 Janssen Pharmaceutica Nv Heterocyclic compounds
WO2004108671A1 (en) * 2003-06-06 2004-12-16 Suven Life Sciences Limited Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them
US7517910B2 (en) 2004-03-30 2009-04-14 Takeda Pharmaceutical Company Limited Alkoxyphenylpropanoic acid derivatives
US7618980B2 (en) 2004-07-14 2009-11-17 Bristol-Myers Squibb Company Pyrrolo(oxo)quinolines as 5HT ligands
US7572805B2 (en) 2004-07-14 2009-08-11 Bristol-Myers Squibb Company Pyrrolo(oxo)isoquinolines as 5HT ligands
JO2769B1 (en) * 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Fast Dissociting Dopamine 2 Receptor Antagonists
JO2642B1 (en) * 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Fast Dissociating Dopamine 2 Receptor Antagonists
JO2849B1 (en) * 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Fast -Dissociating Dopamine 2 Receptor Antagonists
MX2009011416A (en) 2007-04-23 2009-11-05 Janssen Pharmaceutica Nv Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists.
KR20100016620A (en) 2007-04-23 2010-02-12 얀센 파마슈티카 엔.브이. 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
US8530474B2 (en) 2008-07-03 2013-09-10 Janssen Pharmaceutica Nv Substituted 6-(1-piperazinyl)-pyridazines as 5-HT6 receptor antagonists
KR101609218B1 (en) 2008-07-31 2016-04-05 얀센 파마슈티카 엔.브이. Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists
EP3686196B1 (en) * 2017-09-20 2024-06-12 Hangzhou Innogate Pharma Co., Ltd. Polycyclic compound acting as ido inhibitor and/or ido-hdac dual inhibitor
US20230150980A1 (en) * 2020-04-22 2023-05-18 Anima Biotech Inc. Collagen 1 translation inhibitors and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (en) * 1959-09-25 1900-01-01
DE69217224T2 (en) * 1991-07-03 1997-06-05 Pharmacia & Upjohn Co., Kalamazoo, Mich. SUBSTITUTED INDOLE AS ANTI-AIDS PHARMACEUTICAL PREPARATIONS
JPH05255089A (en) * 1991-12-18 1993-10-05 Sanwa Kagaku Kenkyusho Co Ltd Antiviral agent
US5670522A (en) * 1992-10-23 1997-09-23 Merck Sharp & Dohme Limited Dopamine receptor subtype ligands
US5576336A (en) * 1993-03-18 1996-11-19 Merck Sharp & Dohme Limited Indole derivatives as dopamine D4 antagonists
GB9305644D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
US5814644A (en) * 1993-04-15 1998-09-29 Merck Sharp & Dohme, Ltd. Indole derivatives as dopamine D4 antagonists
DE4414113A1 (en) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-indolylpiperidines
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
ZA968661B (en) * 1995-11-17 1998-04-14 Upjohn Co Oxazolidinone antibacterial agent with tricyclic substituents.
TW504510B (en) * 1996-05-10 2002-10-01 Janssen Pharmaceutica Nv 2,4-diaminopyrimidine derivatives

Also Published As

Publication number Publication date
WO1999009025A3 (en) 1999-04-15
BG104069A (en) 2001-05-31
IL133960A0 (en) 2001-04-30
CN1265660A (en) 2000-09-06
EP1003739A2 (en) 2000-05-31
ID23803A (en) 2000-05-11
AR017019A1 (en) 2001-08-22
CO4960656A1 (en) 2000-09-25
ZA987304B (en) 2000-02-14
DZ2583A1 (en) 2003-02-22
TNSN98151A1 (en) 2005-03-15
HUP0003425A2 (en) 2001-10-28
OA11286A (en) 2003-10-22
HRP980441A2 (en) 1999-04-30
SK1352000A3 (en) 2000-08-14
EA200000023A1 (en) 2000-08-28
JP2002536291A (en) 2002-10-29
PE106299A1 (en) 1999-11-02
BR9811557A (en) 2000-08-22
CA2297486A1 (en) 1999-02-25
PA8457001A1 (en) 2000-09-29
HUP0003425A3 (en) 2002-02-28
MA24632A1 (en) 1999-04-01
TR200000414T2 (en) 2000-08-21
AP9801321A0 (en) 2000-02-14
UY25144A1 (en) 2000-12-29
PL338947A1 (en) 2000-12-04
NO20000722D0 (en) 2000-02-14
CA2297486C (en) 2005-05-03
WO1999009025A2 (en) 1999-02-25
KR20010022507A (en) 2001-03-15
AU8457298A (en) 1999-03-08
IS5336A (en) 2000-01-11

Similar Documents

Publication Publication Date Title
NO20000722L (en) 2- (4-aryl or heteroaryl-piperazin-1-ylmethyl) -1H-indole derivatives
MY119150A (en) Azetidine derivatives, their preparation and medicaments containing them
TR200100439T2 (en) 1H-Imidazopyridine derivatives
DK0928788T3 (en) Imidazolidin-4-one derivatives useful as anticancer agents
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
NO996108L (en) 9 oksinerytromycinderivater
FI962418A0 (en) Cyclic amide derivatives as neurokinin A antagonists
DK1263722T3 (en) Pharmaceutical compositions containing azetidine derivative, novel azetidine derivatives and preparation thereof
ATE269312T1 (en) N-(AMIDINOPHENYL)-N'-(NOUN)-3H-2,4-BENZODIAZEPINE-3-ONE DERIVATIVES AS FACTOR XA INHIBITORS
SE9904652D0 (en) Novel Compounds
NO970349D0 (en) Compounds useful as antiproliferative agents and GARFT inhibitors
NO20022558L (en) 4-Carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as CETP inhibitor
NO20052683L (en) New pyridopyrimidinone compounds, processes for their preparation and pharmaceutical compositions containing them
NO20040881L (en) Oral antidiabetic agents.
DK0992509T3 (en) New macrolide derivatives
NO20060147L (en) Benzimidazole derivatives, compositions containing them, their preparation and their use
NO20022232L (en) Imidazole compounds for use as inhibitors of phosphodiesterase VII
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
NO20070157L (en) Substituted diketopiperazines as oxytocin antagonists
NO20022552D0 (en) New benzothiadiazine derivatives, their preparation and pharmaceutical compositions containing the same
NO20060146L (en) Benzimidazole derivatives, compositions containing them, their preparation and their use
NO20022123L (en) Oxoxazole derivatives for use as inhibitors of phosphodiesterase VII
NO961797L (en) Use of benzopyran derivatives for the preparation of pharmaceutical compositions intended for the treatment of pathologies associated with the Na + -independent C1-HCO3 yields
AR027035A1 (en) PIRROLES REPLACED
DK0798298T3 (en) Thiazolidinone or oxazolidone derivatives for the treatment of angina pectoris or compositions containing the same as active ingredient

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application